These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8915300)
41. Adverse events with universal use of iodixanol for CT: comparison with iohexol. Ho AL; O'Malley ME; Tomlinson GA J Comput Assist Tomogr; 2007; 31(2):165-8. PubMed ID: 17414747 [TBL] [Abstract][Full Text] [Related]
42. Adverse reactions following two separate intravascular injections of contrast media in the same patient. A comparison between iohexol and monomeric ionic media. Sogn EE; Odegård T; Haider T; Andrew E Acta Radiol; 1987; 28(1):93-7. PubMed ID: 2952151 [TBL] [Abstract][Full Text] [Related]
43. Preventing Intravenous Contrast Extravasation in CT: A Simple Solution. Conner B; Ash R; Allen W; Brown T; Hill J; Hook M; Fishback S J Am Coll Radiol; 2017 Oct; 14(10):1326-1332. PubMed ID: 28739321 [No Abstract] [Full Text] [Related]
44. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321 [TBL] [Abstract][Full Text] [Related]
45. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Kim KS; Kim K; Hwang SS; Jo YH; Lee CC; Kim TY; Rhee JE; Suh GJ; Singer AJ; Kim HD Am J Emerg Med; 2011 May; 29(4):412-7. PubMed ID: 20825813 [TBL] [Abstract][Full Text] [Related]
46. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children. Smets A; Shaw D Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355 [TBL] [Abstract][Full Text] [Related]
47. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. Peterson CM; Lin M; Pilgram T; Heiken JP J Comput Assist Tomogr; 2011; 35(2):202-5. PubMed ID: 21412090 [TBL] [Abstract][Full Text] [Related]
48. Low osmolar (non-ionic) contrast media versus high osmolar (ionic) contrast media in intravenous urography and enhanced computerized tomography: a cost-effectiveness analysis. Wangsuphachart S Southeast Asian J Trop Med Public Health; 1991 Dec; 22(4):664-76. PubMed ID: 1820658 [TBL] [Abstract][Full Text] [Related]
50. [A fatal case of anaphylactoid shock after administration of nonionic contrast medium]. Shimizu T; Kawasaki Y; Ochiai E; Kisanuki A Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):749-50. PubMed ID: 12508496 [TBL] [Abstract][Full Text] [Related]
51. Enhancement with water-soluble contrast media in computed tomography of the brain and abdomen. Survey and present state. Skalpe IO Acta Radiol Suppl; 1983; 366():72-5. PubMed ID: 6382938 [TBL] [Abstract][Full Text] [Related]
52. Cerebral vaso-occlusive event with low-osmolar intravenous contrast in a patient with sickle cell disease. Zantomio D; Dowling RJ; Grigg A Am J Hematol; 2006 May; 81(5):383. PubMed ID: 16628721 [No Abstract] [Full Text] [Related]
53. Fatal noncardiogenic pulmonary edema related to nonionic, iso-osmolar iodine contrast medium: one case report. Yi KM; Li X BMC Pulm Med; 2022 Mar; 22(1):118. PubMed ID: 35361181 [TBL] [Abstract][Full Text] [Related]
54. Case report: Pontine haemorrhage following iohexol lumbar myelography. Yeh YF; Lin SK; Sung CY; Chu CC; Wu YR Br J Radiol; 1996 Apr; 69(820):368-70. PubMed ID: 8665142 [TBL] [Abstract][Full Text] [Related]
55. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo]. Böhm I; Speck U; Schild H Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838 [TBL] [Abstract][Full Text] [Related]
56. [Acute pulmonary edema from contrast media. A clinical case]. di Lauro E; D'Amato G; Antonucci G; Schinco S; Valeri F Minerva Anestesiol; 1999; 65(7-8):581-7. PubMed ID: 10479847 [TBL] [Abstract][Full Text] [Related]
57. Intravenous contrast media: use and associated mortality. Cashman JD; McCredie J; Henry DA Med J Aust; 1991 Nov; 155(9):618-23. PubMed ID: 1943961 [TBL] [Abstract][Full Text] [Related]
58. A Retrospective Review of Contrast Nephropathy in a General Population. Arayan A; Nigogosyan MA; Van Every MJ WMJ; 2015 Jun; 114(3):95-9. PubMed ID: 27073827 [TBL] [Abstract][Full Text] [Related]
59. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Lasser EC; Lyon SG; Berry CC Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676 [TBL] [Abstract][Full Text] [Related]
60. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]